Last reviewed · How we verify
Placebo for ABBV-951
A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.
At a glance
| Generic name | Placebo for ABBV-951 |
|---|---|
| Sponsor | AbbVie |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo is an inert substance used as a control in clinical trials to establish the efficacy of the active investigational drug ABBV-951 through comparison. Any observed effects in placebo recipients are attributed to natural disease progression, regression to the mean, or the placebo effect rather than pharmacological action.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |